Health technology in the hands of cardiac patients — helpful, hindrance, or hesitate to say?
Cardiovascular disease (CVD) is a leading cause of death and hospital admissions in Australia.1 Almost a third of patients will have a recurrence such as myocardial infarction (MI), stroke, heart failure and death within 5 years.2 Reductions of at least 80% in these events can be achieved through secondary prevention behaviours, including taking cardioprotective medications as prescribed, ceasing smoking, increasing physical activity and consuming a healthy diet.3 The most comprehensive and proven of strategies to support secondary prevention is cardiac rehabilitation. This is an evidence-based, cost-effective method to reduce CVD deaths, assist recovery and promote secondary prevention through reduction of cardiovascular risk factors.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Australian Institute of Health and Welfare. Cardiovascular disease: Australian facts 2011 (AIHW Cat. No. CVD 53). Canberra: AIHW, 2011.
- 2. Kerr AJ, Broad J, Wells S, et al. Should the first priority in cardiovascular risk management be those with prior cardiovascular disease? Heart 2009; 95: 125-129.
- 3. Smith SC Jr, Benjamin EJ, Bonow RO, et al. AHA/ACCF Secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 2011; 124: 2458-2473.
- 4. Shore S, Jones PG, Maddox TM, et al. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction. Heart 2015; 101: 800-807.
- 5. Perel P, Avezum A, Huffman M, et al. Reducing premature cardiovascular morbidity and mortality in people with atherosclerotic vascular disease: the World Heart Federation roadmap for secondary prevention of cardiovascular disease. Global Heart 2015; 10: 99-110.
- 6. Australian Bureau of Statistics. Household use of information technology, Australia, 2014–15. Canberra: ABS, 2016. http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/8146.0Main+Features12014-15?OpenDocument (accessed June 2016).
- 7. Piette JD, List J, Rana GK, et al. Mobile health devices as tools for worldwide cardiovascular risk reduction and disease management. Circulation 2015; 132: 2012-2027.
- 8. Park LG, Beatty A, Stafford Z, Whooley MA. Mobile phone interventions for the secondary prevention of cardiovascular disease. Prog Cardiovasc Dis 2016; 58: 639-650.
- 9. Chow CK, Redfern J, Hillis GS, et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA 2015; 314: 1255-1263.
- 10. Varnfield M, Karunanithi M, Lee CK, et al. Smartphone-based home care model improved use of cardiac rehabilitation in postmyocardial infarction patients: results from a randomised controlled trial. Heart 2014; 100: 1770-1779.
- 11. Alharbi M, Bauman A, Neubeck L, Gallagher R. Validation of Fitbit-Flex as a measure of free-living physical activity in a community-based phase III cardiac rehabilitation population. Eur J Prev Cardiol 2016; doi: 10.1177/2047487316634883 [Epub ahead of print].
- 12. Neubeck L, Lowres N, Benjamin EJ, et al. The mobile revolution — using smartphone apps to prevent cardiovascular disease. Nat Rev Cardiol 2015; 12: 350-360.
- 13. Singh K, Drouin K, Newmark LP, et al. Developing a framework for evaluating the patient engagement, quality, and safety of mobile health applications. Issue Brief (Commonw Fund) 2016; 5: 1-11.
- 14. Or CKL, Karsh BT. A systematic review of patient acceptance of consumer health information technology. J Am Med Inform Assoc 2009; 16: 550-560.
- 15. Buijink AW, Visser BJ, Marshall L. Medical apps for smartphones: lack of evidence undermines quality and safety. Evid Based Med 2013; 18: 90-92.
- 16. Wicks P, Chiauzzi E. “Trust but verify” — five approaches to ensure safe medical apps. BMC Med 2015; 13: 205.
- 17. Trend Micro™. How vetting mobile apps works for app stores and its users. 2014. http://www.trendmicro.com/vinfo/us/security/news/mobile-safety/vetting-mobile-apps-works-for-app-stores-and-users (accessed June 2016).
No relevant disclosures.